Cetera Investment Advisers Regeneron Pharmaceuticals, Inc. Transaction History

Cetera Investment Advisers

$42.2 Billion
Q2 2024

A detailed history of Cetera Investment Advisers transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 7,946 shares of REGN stock, worth $6.55 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

7,946

Previous 9,753 18.53%

Holding current value

$6.55 Million

Previous $9.39 Million 11.04%

% of portfolio

0.02%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 22, 2024	SELL	$883.2 - $1071.19 $1.6 Million - $1.94 Million	-1,807 Reduced 18.53%	7,946 $8.35 Million
Q1 2024 May 24, 2024	BUY	$902.69 - $993.35 $6.91 Million - $7.6 Million	7,651 Added 363.99%	9,753 $9.39 Million
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $1.53 Million - $1.68 Million	-1,696 Reduced 44.66%	2,102 $2.02 Million
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $91,471 - $104,040	118 Added 3.21%	3,798 $3.34 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $78,939 - $96,258	-114 Reduced 3.0%	3,680 $3.03 Million
Q2 2023 Aug 09, 2023	BUY	$700.03 - $830.35 $63,002 - $74,731	90 Added 2.43%	3,794 $2.73 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $346,369 - $420,927	509 Added 15.93%	3,704 $3.04 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $1.25 Million - $1.36 Million	1,771 Added 124.37%	3,195 $2.31 Million
Q3 2022 Nov 10, 2022	SELL	$573.97 - $724.32 $754,770 - $952,480	-1,315 Reduced 48.01%	1,424 $981,000
Q2 2022 Aug 11, 2022	SELL	$548.35 - $738.84 $154,634 - $208,352	-282 Reduced 9.33%	2,739 $1.62 Million
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $36,897 - $43,302	-62 Reduced 2.01%	3,021 $2.11 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $249,457 - $307,975	459 Added 17.49%	3,083 $1.95 Million
Q3 2021 Nov 16, 2021	BUY	$574.03 - $680.96 $30,997 - $36,771	54 Added 2.1%	2,624 $1.59 Million
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $89,359 - $105,564	-189 Reduced 6.85%	2,570 $1.44 Million
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $215,770 - $264,780	483 Added 21.22%	2,759 $1.31 Million
Q4 2020 Feb 17, 2021	BUY	$478.3 - $607.98 $1.09 Million - $1.38 Million	2,276 New	2,276 $1.1 Million

Others Institutions Holding REGN

# of Institutions

1,492

Shares Held

85.8M

Call Options Held

908K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $88.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Account

Cetera Investment Advisers Regeneron Pharmaceuticals, Inc. Transaction History